Amrutanjan Health Care Ltd Company Profile:Products,Promoters and Clients

AHCL Company Description

AHCL specializes in manufacturing ayurvedic balms for pain management and is currently managed by its third-generation promoters. With over 120 years of experience, the company has diversified into over-the-counter (OTC) products for pain management, women's hygiene, and packaged fruit juice drinks.

Q1. What are the Products and Service offerings of the Company?

OTC Products: AHCL's OTC lineup includes:

  • Head Category: Featuring Amrutanjan roll-ons and balms.
  • Body Category: Offering pain relief roll-ons, patches, and balms.
  • Congestion Category: Providing relief from cold and cough through beverages and inhalers. AHCL dominates the roll-on segment with a commanding 73% market share.

Women’s Hygiene and Beverages:

  • Women’s Hygiene: Marketed under the brand Comfy, which includes sanitary napkins.
  • Beverages: Includes Electro+ energy drinks, endorsed by cricketer Ruturaj Gaikwad and serving as the Tour Partner for the Professional Golf Tour of India.

Q2. Who are the Promoters of the Company?

AHCL is led by its third-generation promoters:

  • Mr. Dineshkumar Tribhivanbhai Rathod: With a background in ayurvedic medicine and business management, Mr. Rathod provides strategic direction and leadership.
  • Mr. Nikunj Navinbhai Sanghani: Known for his expertise in international trade and market expansion, Mr. Sanghani drives global growth initiatives for AHCL.
  • Ms. Manisha Patel Maneklal: A seasoned professional in finance and corporate governance, Ms. Maneklal oversees financial strategies and compliance to ensure operational excellence.

Q3. Who are the Clients of the Company?

AHCL operates primarily through a B2C model, serving a diverse customer base with its portfolio of brands:

  • OTC Products: Representing 90% of sales, with brands like Amrutanjan and Comfy (28% market share).
  • Beverages: Contributing 10% of sales, primarily through Electro+ (83% market share in its segment).

(All information reflects data as of FY'23)